Newsroom

Apersys device enables pharmacological-induced defatting of human liver

Tuesday, 02.04.2024

Apersys granted Breakthrough Device Designation from the FDA

Thursday, 20.03.2024

Cutting-edge machine enables fat removal from human liver 

Tuesday, 31.05.2023

First in-human liver transplant after 3 days perfusion

Tuesday, 31.05.2022

For media enquiries
Members of the media can contact us at info@apersys.ch

Apersys AG

Apersys AG

c/o ETH Zürich

Weinbergstrasse 35

WEH F, 8092 Zürich

Schweiz

Privacy Notice

Imprint

© Apersys 2024
All rights reserved

Get in Touch

Linkedin X-twitter Envelope